课题基金 / 基金详情

MOLECULAR ARCHITECTURE OF THE NA/GLUCOSE COTRANSPORTER

MOLECULAR ARCHITECTURE OF THE NA/GLUCOSE COTRANSPORTER
NA/葡萄糖协同转运蛋白的分子结构
批准号:
2143911
负责人:
ERNEST M WRIGHT
金额:
$20.86万
依托单位国家:
美国
项目类别:
财政年份:
1992
资助国家:
美国
项目状态:
已结题
起止时间:
1992-09-30 至 1996-09-29

项目摘要

项目成果

ERNEST M WRIGHT的其他基金

相似基金

相关文献

中文摘要
翻译
这项提议的长期目标是确定Na+/葡萄糖如何
英文摘要
The long-term aim of this proposal is to determine how the Na+/glucose cotransporter actually transports Na+ and glucose across the membrane. To achieve this aim it is necessary to unravel the molecular architecture of the transport protein. The short-term goal is to identify the Na+ and sugar binding sites of the protein and the long-term goal is to delineate the structural topology and conformations of the isolated protein. The Na+, sugar and inhibitor (phlorizin) binding sites on the cotransporter will be identified using three strategies: The first, is to label the Na+/glucose cotransport in brush border membrane vesicles at tyrosine residues occurring at the Na+ binding site, and lysine residues at the glucose and phlorizin binding sites. The protein will be cleaved by proteolysis, purified, and sequenced; The second, is to employ molecular engineering techniques to mutate tyrosine and lysine residues thought to be at the active sites. We will then determine whether or not these are the residues labeled by group specific reagents, and establish whether or not the tyrosine and/or lysine residues are critically involved in Na+/glucose cotransport; and third, we will use molecular techniques to test the hypothesis that Gly43 and Arg300 are involved in Na+ binding and transport. Transport properties of mutants will be assayed in Xenopus oocytes, and immunoprecipitation techniques will be utilized to confirm the presence of the mutant proteins in the oocyte plasma membrane. Our initial strategy toward achieving the long-term goal of purifying the Na+/glucose cotransporter will involve overexpression in E. coli and in cultured insect cells. Fusion proteins will be expressed in bacteria, and baculovirus constructs will be used to overexpress the cotransporter in sf9 cells. With high expression levels, at least two orders of magnitude greater than in enterocytes, we will be well positioned to purify the protein by electrophoresis and chromatography. The protein will first be used to raise antibodies, but the long-term objective is to use the protein for structure and functional studies.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Role of SGLTs in Glucose Homeostasis and Tissue Metabolism
Role of SGLTs in Glucose Homeostasis and Tissue Metabolism
MOLECULAR CLONING OF BLOOD/BRAIN BARRIER NUTRIENT TRANSPORTERS
MOLECULAR CLONING OF BLOOD/BRAIN BARRIER NUTRIENT TRANSPORTERS
海外基金